Binding Antibodies Total LD MD HD
Day 15 (week 2 67% (+) 25% (+) 87% (+) 92% (+)
Day 29 (week 5 100% (+) 100% (+) 100% (+) 100% (+)
Day 43 (week 7 100% (+) 100% (+) 100% (+) 100% (+)
Day 85 (week 13 100% (+) 100% (+) 100% (+) 100% (+)
Neutralizing Antibodies  
Day 15 (week 2 52% (+)
Day 29 (week 5) 96% (+)
Day 43 (week 7) 89% (+)
Table 1: Determination of binding (ADAs) and neutralizing antibodies in non human primates treated with PEG-IFNα-2B during 13 weeks by the subcutaneous route. LD: Low Dose; MD: Mid Dose; HD: High Dose.
Goto home»